DiNuzzo Private Wealth’s Jazz Pharmaceuticals JAZZ Stock Holding History

DiNuzzo Private Wealth’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.13K	Hold	13	–	–	﹤0.01%	523
2026 Q1	$2.46K	Hold	13	–	–	﹤0.01%	569
2025 Q4	$2.21K	Hold	13	–	–	﹤0.01%	609
2025 Q3	$1.66K	Hold	13	–	–	﹤0.01%	708
2025 Q2	$1.38K	Hold	13	–	–	﹤0.01%	755
2025 Q1	$1.61K	Buy	13 +1	+8%	+$130	﹤0.01%	664
2024 Q4	$1.48K	Hold	12	–	–	﹤0.01%	711
2024 Q3	$1.34K	Buy	12 +2	+20%	+$219	﹤0.01%	759
2024 Q2	$1.07K	Sell	10 -2	-17%	-$220	﹤0.01%	771
2024 Q1	$1.45K	Buy	12 +2	+20%	+$245	﹤0.01%	598
2023 Q4	$1.23K	Buy	+10	New	+$1.25K	﹤0.01%	629

Other funds holding JAZZ

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

ACM

Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

DiNuzzo Private Wealth's JAZZ Position: Q2 2026 in Review

DiNuzzo Private Wealth held its Jazz Pharmaceuticals (JAZZ) position steady in Q2 2026 at 13 shares worth $3.13K. The position accounts for ﹤0.01% of the portfolio, ranked #523.

DiNuzzo Private Wealth first reported a position in JAZZ in Q4 2023 and has held it in 11 quarters since. 182 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

DiNuzzo Private Wealth held 13 shares of Jazz Pharmaceuticals worth $3.13K as of Q2 2026.
DiNuzzo Private Wealth left its Jazz Pharmaceuticals share count unchanged in Q2 2026.
Jazz Pharmaceuticals made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q2 2026, its #523 holding.
DiNuzzo Private Wealth first reported a position in Jazz Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
182 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q2 2026, filed 10 Jul 2026.